Christopher Seaton is a Board Member at Versantis. Christopher was previously the Chairman of the Board at Middlesex Hospital from January 2008 to December 2014. Prior to that, they were the Senior Vice President of Negotiations at Bayer HealthCare from September 1995 to April 2018, where they were responsible for major Licensing and BD transactions at Bayer Pharmaceuticals. From August 1991 to August 1995, they worked as the Finance, Planning and IT Manager at ICI Chlor-Chemicals, responsible for all Finance and Planning activities of ICI's international Chlor-Chemicals business. Christopher also worked as a consultant at SummerHill Consulting, LLC, and as the Director of Business Administration at ICI Pharmaceuticals from January 1988 to December 1991.
Christopher Seaton's educational career includes a Master of Business Administration from McMaster University and a Bachelor of Commerce from Kingston College in Jamaicas.